These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8983024)

  • 1. Positive and negative modulation of H-ras transforming potential by mutations of phenylalanine-28.
    Ricketts MH; Durrheim GA; North HM; van der Merwe MJ; Levinson AD
    Mol Biol Rep; 1996; 23(2):109-17. PubMed ID: 8983024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological and structural characterization of a Ras transforming mutation at the phenylalanine-156 residue, which is conserved in all members of the Ras superfamily.
    Quilliam LA; Zhong S; Rabun KM; Carpenter JW; South TL; Der CJ; Campbell-Burk S
    Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1272-6. PubMed ID: 7877967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternate mechanisms of ras activation are complementary and favor and formation of ras-GTP.
    Patel G; MacDonald MJ; Khosravi-Far R; Hisaka MM; Der CJ
    Oncogene; 1992 Feb; 7(2):283-8. PubMed ID: 1549350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p21 with a phenylalanine 28----leucine mutation reacts normally with the GTPase activating protein GAP but nevertheless has transforming properties.
    Reinstein J; Schlichting I; Frech M; Goody RS; Wittinghofer A
    J Biol Chem; 1991 Sep; 266(26):17700-6. PubMed ID: 1894650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ras effector loop mutations that dissociate p120GAP and neurofibromin interactions.
    Stang S; Bottorff D; Stone JC
    Mol Carcinog; 1996 Jan; 15(1):64-9. PubMed ID: 8561868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structures at 2.2 A resolution of the catalytic domains of normal ras protein and an oncogenic mutant complexed with GDP.
    Tong LA; de Vos AM; Milburn MV; Kim SH
    J Mol Biol; 1991 Feb; 217(3):503-16. PubMed ID: 1899707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. trans-Dominant suppressor mutations of the H-ras oncogene.
    Ogiso Y; Gutierrez L; Wrathall LS; Lu YY; Blair DG; Clanton DJ; Hwang YW; Shih TY
    Cell Growth Differ; 1990 May; 1(5):217-24. PubMed ID: 2150753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A synthetic peptide corresponding to a sequence in the GTPase activating protein inhibits p21ras stimulation and promotes guanine nucleotide exchange.
    Rubinfeld B; Wong G; Bekesi E; Wood A; Heimer E; McCormick F; Polakis P
    Int J Pept Protein Res; 1991 Jul; 38(1):47-53. PubMed ID: 1938104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of guanine nucleotide bound to ras protein in PC12 cells.
    Satoh T; Endo M; Nakamura S; Kaziro Y
    FEBS Lett; 1988 Aug; 236(1):185-9. PubMed ID: 3042464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies specific for amino acid 12 of the ras oncogene product inhibit GTP binding.
    Clark R; Wong G; Arnheim N; Nitecki D; McCormick F
    Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5280-4. PubMed ID: 3927300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and function of p21 ras proteins.
    Shih TY; Hattori S; Clanton DJ; Ulsh LS; Chen ZQ; Lautenberger JA; Papas TS
    Gene Amplif Anal; 1986; 4():53-72. PubMed ID: 3333361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of glutamine-61 in the hydrolysis of GTP by p21H-ras: an experimental and theoretical study.
    Frech M; Darden TA; Pedersen LG; Foley CK; Charifson PS; Anderson MW; Wittinghofer A
    Biochemistry; 1994 Mar; 33(11):3237-44. PubMed ID: 8136358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-ray crystal structures of transforming p21 ras mutants suggest a transition-state stabilization mechanism for GTP hydrolysis.
    Privé GG; Milburn MV; Tong L; de Vos AM; Yamaizumi Z; Nishimura S; Kim SH
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3649-53. PubMed ID: 1565661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton NMR studies of transforming and nontransforming H-ras p21 mutants.
    Schlichting I; John J; Frech M; Chardin P; Wittinghofer A; Zimmermann H; Rösch P
    Biochemistry; 1990 Jan; 29(2):504-11. PubMed ID: 2405906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/GTP exchange factor.
    Bustelo XR; Suen KL; Leftheris K; Meyers CA; Barbacid M
    Oncogene; 1994 Aug; 9(8):2405-13. PubMed ID: 8036025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological and biochemical properties of human rasH genes mutated at codon 61.
    Der CJ; Finkel T; Cooper GM
    Cell; 1986 Jan; 44(1):167-76. PubMed ID: 3510078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rabbit intestine contains a protein that inhibits the dissociation of GDP from and the subsequent binding of GTP to rhoB p20, a ras p21-like GTP-binding protein.
    Ohga N; Kikuchi A; Ueda T; Yamamoto J; Takai Y
    Biochem Biophys Res Commun; 1989 Sep; 163(3):1523-33. PubMed ID: 2506864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of p21ras.GTP in response to stimulation with epidermal growth factor and oncogene products with tyrosine kinase activity.
    Satoh T; Endo M; Nakafuku M; Akiyama T; Yamamoto T; Kaziro Y
    Proc Natl Acad Sci U S A; 1990 Oct; 87(20):7926-9. PubMed ID: 2146678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional structure of p21H-ras and its implications.
    Wittinghofer F
    Semin Cancer Biol; 1992 Aug; 3(4):189-98. PubMed ID: 1421163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic aspects of signaling through Ras in NIH 3T3 cells.
    Zhang K; Papageorge AG; Lowy DR
    Science; 1992 Jul; 257(5070):671-4. PubMed ID: 1496380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.